RBC Capital analysts cut Surgery Partners' price target from $22 to $20, according to Financial Market News.
Here are five notes:
1. The analysts have an "outperform" rating on Surgery Partners' shares.
2. RBC Capital's price target indicates a potential upside of 25 percent from Surgery Partners' previous close.
3. Surgery Partners has a 12-month high of $22.32 and 12-month low of $11.97.
4. The company has a market cap of $770.50 million.
5. For the fourth quarter, Surgery Partners had an EPS of $0.35.
For more on Surgery Partners' fourth quarter results, click here.
More articles on surgery centers:
Children's Hospital of Richmond at VCU to open outpatient pavilion: 4 notes
OhioHealth to expand outpatient services: 4 things to know
4 key points on DuPage Medical Group acquiring Midwest ENT Consultants